Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells
Authors
Keywords
-
Journal
ENDOCRINE-RELATED CANCER
Volume 21, Issue 5, Pages 723-737
Publisher
Bioscientifica
Online
2014-07-01
DOI
10.1530/erc-14-0267
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biomarkers to guide therapy or surveillance for prostate cancer
- (2013) Deborah Citrin et al. Biomarkers in Medicine
- Targeting the PI3K/Akt/mTOR pathway in castration-resistant prostate cancer
- (2013) Rhonda L Bitting et al. ENDOCRINE-RELATED CANCER
- Castration-Resistant Prostate Cancer: From New Pathophysiology to New Treatment
- (2013) Srikala S. Sridhar et al. EUROPEAN UROLOGY
- Synergistic Targeting of PI3K/AKT Pathway and Androgen Receptor Axis Significantly Delays Castration-Resistant Prostate Cancer ProgressionIn Vivo
- (2013) Christian Thomas et al. MOLECULAR CANCER THERAPEUTICS
- New Agents in the Arsenal to Fight Castrate-Resistant Prostate Cancer
- (2013) Erin E. Ezzell et al. Current Oncology Reports
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer risk by combined levels of YKL-40 and C-reactive protein in the general population
- (2011) K H Allin et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity
- (2011) Sarat Chandarlapaty et al. CANCER CELL
- Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth
- (2011) David J. Mulholland et al. CANCER CELL
- Carbohydrate-binding motif in chitinase 3-like 1 (CHI3L1/YKL-40) specifically activates Akt signaling pathway in colonic epithelial cells
- (2011) Chun-Chuan Chen et al. CLINICAL IMMUNOLOGY
- Contemporary Role of Androgen Deprivation Therapy for Prostate Cancer
- (2011) Vincenzo Pagliarulo et al. EUROPEAN UROLOGY
- Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: Decreased tumor metastasis in a breast cancer model
- (2011) Stephania Libreros et al. INTERNATIONAL JOURNAL OF CANCER
- A Complex of Nuclear Factor I-X3 and STAT3 Regulates Astrocyte and Glioma Migration through the Secreted Glycoprotein YKL-40
- (2011) Sandeep K. Singh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of YKL-40 in the Angiogenesis, Radioresistance, and Progression of Glioblastoma
- (2011) Ralph A. Francescone et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A YKL-40-Neutralizing Antibody Blocks Tumor Angiogenesis and Progression: A Potential Therapeutic Agent in Cancers
- (2011) M. Faibish et al. MOLECULAR CANCER THERAPEUTICS
- Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer
- (2011) M Kawada et al. ONCOGENE
- Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion
- (2011) Meng Sun et al. PROSTATE
- Transcription Factor Stat3 Stimulates Metastatic Behavior of Human Prostate Cancer Cells in Vivo, whereas Stat5b Has a Preferential Role in the Promotion of Prostate Cancer Cell Viability and Tumor Growth
- (2010) Lei Gu et al. AMERICAN JOURNAL OF PATHOLOGY
- Recent developments in prostate cancer biomarker research: therapeutic implications
- (2010) Sujitra Detchokul et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells
- (2010) Bo Mi Ku et al. INTERNATIONAL JOURNAL OF CANCER
- Plasma YKL-40: a potential new cancer biomarker?
- (2009) Julia S Johansen et al. Future Oncology
- YKL-40, a secreted glycoprotein, promotes tumor angiogenesis
- (2009) R Shao et al. ONCOGENE
- Optimizing molecular signatures for predicting prostate cancer recurrence
- (2009) Yijun Sun et al. PROSTATE
- Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer
- (2008) Deniz Yamac et al. ADVANCES IN THERAPY
- Stat3 Promotes Metastatic Progression of Prostate Cancer
- (2008) Junaid Abdulghani et al. AMERICAN JOURNAL OF PATHOLOGY
- Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia
- (2008) Mine Kucur et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search